Correlation Between Arcus Biosciences and Mind Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Mind Medicine, you can compare the effects of market volatilities on Arcus Biosciences and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Mind Medicine.

Diversification Opportunities for Arcus Biosciences and Mind Medicine

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Arcus and Mind is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Mind Medicine go up and down completely randomly.

Pair Corralation between Arcus Biosciences and Mind Medicine

Given the investment horizon of 90 days Arcus Biosciences is expected to under-perform the Mind Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Arcus Biosciences is 1.42 times less risky than Mind Medicine. The stock trades about -0.05 of its potential returns per unit of risk. The Mind Medicine is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  622.00  in Mind Medicine on September 23, 2024 and sell it today you would earn a total of  94.00  from holding Mind Medicine or generate 15.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Arcus Biosciences  vs.  Mind Medicine

 Performance 
       Timeline  
Arcus Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Mind Medicine 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Mind Medicine are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Mind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Arcus Biosciences and Mind Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcus Biosciences and Mind Medicine

The main advantage of trading using opposite Arcus Biosciences and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.
The idea behind Arcus Biosciences and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios